• LAST PRICE
    2.1100
  • TODAY'S CHANGE (%)
    Trending Down-0.0100 (-0.4717%)
  • Bid / Lots
    2.1100/ 1
  • Ask / Lots
    2.1300/ 2
  • Open / Previous Close
    2.1400 / 2.1200
  • Day Range
    Low 2.0800
    High 2.1599
  • 52 Week Range
    Low 2.0600
    High 8.7800
  • Volume
    44,372
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 2.12
TimeVolumeLIFE
09:32 ET5022.14
09:46 ET2002.1599
09:50 ET2022.09
09:51 ET2002.09
09:53 ET2002.08
09:55 ET2002.08
09:57 ET2002.08
10:02 ET2002.08
10:06 ET2002.08
10:11 ET30752.12
10:13 ET1002.11
10:15 ET24002.11
10:18 ET41182.11
10:20 ET1002.115
10:22 ET1002.115
10:24 ET1002.11
10:26 ET1002.11
10:29 ET2002.11
10:31 ET1002.11
10:33 ET3962.11
10:38 ET1002.11
10:40 ET1002.09
10:45 ET1002.08
10:47 ET1002.08
10:49 ET26002.09
10:54 ET1002.1
10:56 ET1002.1
11:00 ET1002.1
11:02 ET2002.1
11:05 ET1002.1
11:07 ET10882.1
11:12 ET1002.1
11:14 ET14932.1
11:16 ET1002.09
11:20 ET1002.09
11:21 ET1002.09
11:25 ET1002.09
11:27 ET1002.09
11:38 ET1002.08
11:39 ET1002.08
11:43 ET1002.08
11:45 ET1002.08
11:50 ET1002.08
11:54 ET1002.08
11:56 ET1002.08
11:59 ET1002.09
12:01 ET10002.09
12:03 ET6002.1
12:06 ET7962.09
12:08 ET10002.095
12:10 ET1002.08
12:14 ET1002.08
12:15 ET1002.08
12:17 ET10002.1
12:21 ET1952.1
12:30 ET2002.08
12:35 ET2002.08
12:42 ET1002.09
12:46 ET1002.09
12:50 ET1002.09
12:53 ET5962.09
01:02 ET1002.09
01:08 ET1002.1
01:09 ET1002.09
01:22 ET4842.09
01:29 ET29002.11
01:36 ET1002.0901
01:40 ET14002.1072
01:58 ET9002.1124
02:02 ET9002.12
02:07 ET7002.1
02:27 ET1002.1
02:34 ET26002.12
02:36 ET3002.1
02:41 ET1002.1001
02:54 ET1002.1
03:08 ET1002.09
03:14 ET1002.09
03:19 ET2002.09
03:28 ET1002.11
03:30 ET2002.11
03:32 ET1002.1
03:37 ET1002.1
03:46 ET2002.115
03:48 ET1002.1
03:51 ET2002.12
03:55 ET2002.13
03:57 ET7722.12
04:00 ET13032.11
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLIFE
aTyr Pharma Inc
61.5M
-1.3x
---
United StatesANEB
Anebulo Pharmaceuticals Inc
61.5M
-7.1x
---
United StatesPRDS
Pardes Biosciences Inc
61.5M
-0.6x
---
United StatesTALS
Talaris Therapeutics Inc
61.3M
-0.9x
---
United StatesRPHM
Reneo Pharmaceuticals Inc
60.8M
-1.1x
---
United StatesAURX
Nuo Therapeutics Inc
62.7M
-17.8x
---
As of 2022-11-29

Company Information

aTyr Pharma, Inc. is a biotherapeutics company engaged in the discovery and development of medicines based on novel biological pathways. Its therapeutic candidate pipeline includes efzofitimod (ATYR1923), ATYR2810, NRP2 mAbs, AARS-1 and DARS-1. The ATYR1923, is a fusion protein comprised of the immunomodulatory domain of histidyl-tRNA synthetase fused to the fragment crystallizable (Fc) region of a human antibody and serves as a selective modulator of NRP2 that downregulates innate and adaptive immune response in inflammatory disease states. The Company is also developing efzofitimod as a potential disease-modifying therapy for patients with fibrotic lung diseases with high unmet medical need. ATYR2810 is a fully humanized monoclonal antibody that specifically and functionally blocks the interaction between NRP2 and one of its primary ligands VEGF. ATYR2810 is in preclinical development for the potential treatment of certain aggressive cancers where NRP2 is implicated.

Contact Information

Headquarters
3545 John Hopkins Ct Ste 250SAN DIEGO, CA, United States 92121-1115
Phone
858-731-8389
Fax
858-731-8394

Executives

Independent Chairman of the Board
John Clarke
President, Chief Executive Officer, Director
Sanjay Shukla
Chief Financial Officer
Jill Broadfoot
General Counsel, Corporate Secretary
Nancy Denyes
Independent Director
Timothy Coughlin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$61.5M
Revenue (TTM)
$0.00
Shares Outstanding
29.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.33
EPS
$-1.65
Book Value
$3.93
P/E Ratio
-1.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.